Egypt, Colombia discuss medical support for Palestinians injured in Gaza    Egypt greenlights new public free zones to drive export growth    PM Madbouly reviews progress of 1.5 Million Feddan Project    PM Madbouly reviews progress on electricity supply for New Delta agricultural development projects    Australia to recognise Palestinian state in September, New Zealand to decide    Trump orders homeless out of DC, deploys federal agents and prepares National Guard    Egypt, Côte d'Ivoire hold political talks, sign visa deal in Cairo    Egypt's TMG H1 profit jumps as sales hit record EGP 211bn    Egyptian pound stable vs. USD at Monday's close    Egypt, Germany FMs discuss Gaza escalation, humanitarian crisis    Egypt, Huawei explore healthcare digital transformation cooperation    Global matcha market to surpass $7bn by 2030: Nutrition expert    Egypt, Huawei discuss expanding AI, digital healthcare collaboration    Egypt's Sisi, Sudan's Idris discuss strategic ties, stability    Egypt's govt. issues licensing controls for used cooking oil activities    Egypt to inaugurate Grand Egyptian Museum on 1 November    Oil rises on Wednesday    Egypt, Uganda strengthen water cooperation, address Nile governance    Egypt's Sisi: Egypt is gateway for aid to Gaza, not displacement    Egypt, Malawi explore pharmaceutical cooperation, export opportunities    Egypt's Foreign Minister discusses Nile water security with Ugandan president    Egyptians vote in two-day Senate election with key list unopposed    Korean Cultural Centre in Cairo launches folk painting workshop    Egyptian Journalist Mohamed Abdel Galil Joins Golden Globe Voting Committee    Egypt keeps Gaza aid flowing, total tops 533,000 tons: minister    Foreign, housing ministers discuss Egypt's role in African development push    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Egypt receives samples of Japanese flu drug Avigan to treat coronavirus
Published in Amwal Al Ghad on 09 - 04 - 2020

Egypt has received samples of a Japanese flu drug – known as Avigan – that could be used as a treatment of the coronavirus pandemic, its minister of higher education said on Thursday.
Egyptian authorities had conducted talks with the Japanese government to receive the samples of the antiviral drug to launch small trials around one month ago, Khaled Abdel Ghaffar said at local TV channel.
The antiviral drug, which is also known as favipiravir, has emerged as a potential drug to treat patients infected with the coronavirus. It has been developed by Japanese company Fujifilm Toyama Chemical Company, a unit of Fujifilm Holdings.
The U.S. Food and Drug Administration (FDA) has on Wednesday given the green light for the country's first clinical trial of the new drug, to be used by three Massachusetts hospitals.
Massachusetts General Hospital, Brigham and Women's Hospital, and UMass Memorial Health Care in Worcester will launch small trials of the drug, a doctor involved in the efforts told the Boston Globe. The U.S. trials would involve around 50 or 60 patients with the coronavirus, the Boston Globe reported.
Dr. Keith T. Flaherty from the Massachusetts General Hospital further told the Boston Global that the Avigan study was among the more promising of around 30 clinical trials considered by the hospital.
In China, the drug was hailed by health officials there as "clearly effective" when used on 340 patients in trials in the Chinese city of Shenzhen, as it showed reduced recovery time and improved lung function, The New York Post reported.
These patients tested negative for the virus with a median of four days after becoming positive — much lower than the average of 11 days for those who were not given the medicine, according to the Guardian.
On April 5, Japan's Chief Cabinet Secretary Yoshihide Suga said his country intends to provide nations stricken by the coronavirus pandemic with the Avigan free of charge. He said the clinical trials were underway in the Asian country to ensure its effectiveness and safety for potential use in treating symptoms caused by the virus.
The Japanese government had so far received requests for the new drug from more than 30 countries, Suga added.
The government plans to expand clinical trials of Avigan while having discussions with the countries that placed the requests, he said.
Japan intends to provide each of those nations with the amount of the drug they need, free of charge, Suga asserted.
A week earlier, Nikkei Asian Review reported that the German government wants to buy large amounts of Avigan to treat coronavirus patients with severe illness.
Germany is aiming for short-term stockpiling of Avigan, according to Frankfurter Allgemeine Zeitung.


Clic here to read the story from its source.